about
Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeysShortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malariaStructural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cellsAnti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULESHow frequently do clusters occur in hierarchical clustering analysis? A graph theoretical approach to studying ties in proximityIdentifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regionsPlasmodium falciparum normocyte binding protein (PfNBP-1) peptides bind specifically to human erythrocytes.P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes.Chromatographic characterization of synthetic peptides: SPf66 malaria vaccine.MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.Elongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.Immunodiagnosis of parasitic diseases with synthetic peptides.Bacterial genotoxins promote inside-out integrin β1 activation, formation of focal adhesion complexes and cell spreading.A rational strategy for a malarial vaccine development.Identification of Plasmodium falciparum RhopH3 protein peptides that specifically bind to erythrocytes and inhibit merozoite invasion.Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bondsA New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35.Development of designed site-directed pseudopeptide-peptido-mimetic immunogens as novel minimal subunit-vaccine candidates for malaria.Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine.Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine.Characterization of a reduced peptide bond analogue of a promiscuous CD4 T cell epitope derived from the Plasmodium falciparum malaria vaccine candidate merozoite surface protein 1.Functionally relevant proteins in Plasmodium falciparum host cell invasion.Schistosoma mansoni infection in owl monkeys (Aontus nancymai): evidence for the early elimination of adult worms.α-Helix peptides designed from EBV-gH protein display higher antigenicity and induction of monocyte apoptosis than the native peptide.Identification of peptides with high red blood cell and hepatocyte binding activity in the Plasmodium falciparum multi-stage invasion proteins: PfSPATR and MCP-1.Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells.Herpesvirus saimiri immortalization of Aotus T lymphocytes specific for an immunogenically modified peptide of Plasmodium falciparum merozoite surface antigen 2.MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6.Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae.Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization.Constitutive alpha V beta 3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate.Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP).Plasmodium falciparum: binding studies of peptide derived from the sporozoite surface protein 2 to Hep G2 cells.Monosaccharides modulate HCV E2 protein-derived peptide biological properties.Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes.Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.
P50
Q27641096-1601CBDF-540D-4C18-B683-AC6254057926Q27643097-88163E84-508F-4248-892D-EF0F1EB55EBBQ27652547-2D53305B-B6FC-4207-B8B2-B1970874FC5FQ27662791-C9AC3B85-5791-49FB-9657-528916533FDAQ27666345-49E68574-2974-40B1-A955-95B0E8A187DFQ27902252-6F7DB409-3787-401F-B896-82A28857A451Q30039319-F001DD42-04E5-428D-A691-A469BFE9EBCCQ30743544-5D404C26-BC06-4148-BC22-BB51A73335C9Q30743558-A94DC330-C9AF-456B-B611-617A6A56E02DQ31036853-E21966E4-0216-415D-B116-2FADE5A07407Q31137274-4D79273B-2418-406A-8AC0-475861CD1F51Q33214973-AF98BEBF-E84E-4126-B431-ECCF917B65CCQ34125960-3E9D83F6-B96C-4114-82F6-F5151C7722A2Q35552246-D0347F5A-B075-4583-9B17-FB6A190F458BQ35601776-300B5B3C-FD5F-4A99-8F7F-96C74502B4EAQ36792065-BDE89FD3-5212-436F-A94C-E9FCA0208DC1Q36901632-A965BDDD-F58F-41A0-8985-702DD28DD8E1Q37180346-8515D321-E5C5-40E9-B375-5736F5987E33Q37516080-69CD1CA3-7AD9-48CB-8BBE-740949CF329AQ37816902-F41B300C-F098-4273-8973-1B9CE14BB23AQ37949675-CE7298B8-C619-44DB-B9C0-BC386E6EBB5EQ38059750-6DCABC37-B276-48DC-8222-A0AED592AF4AQ38896118-9D99DD26-4094-4148-B91E-CA8C908ABA39Q39106485-55BD0EE6-CF6E-4269-811A-174E1C9D7DD0Q39311149-682BFC45-B671-47E4-BCE0-39336129A683Q39703319-0F1D3FB4-4075-40D4-AFFA-D7F9D08A0877Q39933146-AABF816D-941D-47B6-A483-7DA473AB32FFQ40387241-43192713-F6E8-48C7-856E-A3BDD32B0C30Q40468637-0AD36815-E7A5-45AB-9603-A9EB64C08058Q40576181-0D767ABC-BEED-4981-86AD-33A839DEF6E5Q40755540-CFEC0724-396B-40CC-92DC-97B0F44ED94FQ40932991-74E915BB-881A-4BC4-9830-64DB570C66C6Q41377834-2EA2FCA6-4D13-47C5-B51E-E7B7A5D71C12Q42599106-C650A283-FAC4-49C3-A6DE-96C09E200376Q42661670-0E88A560-743E-483E-8251-74FD3768FDA0Q43036066-A4C36B83-A1B8-4679-B09B-A305BB1F899EQ43521372-AFAFFACA-BF04-4AEF-9BF9-0965816FD19FQ43521852-46F83ED6-4A7A-4D65-A55B-53273B7FAA41Q43871088-793F1072-19F4-48DA-A4CF-D85CBD769CF1Q43905631-EE4289AB-C921-460E-923B-FC2C16A02388
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manuel-Elkin Patarroyo
@en
Patarroyo ME
@ast
Patarroyo ME
@es
Patarroyo ME
@nl
Patarroyo ME
@sl
type
label
Manuel-Elkin Patarroyo
@en
Patarroyo ME
@ast
Patarroyo ME
@es
Patarroyo ME
@nl
Patarroyo ME
@sl
altLabel
Patarroyo ME
@en
Patarroyo Manuel Elkin
@en
prefLabel
Manuel-Elkin Patarroyo
@en
Patarroyo ME
@ast
Patarroyo ME
@es
Patarroyo ME
@nl
Patarroyo ME
@sl
P1053
S-1422-2017
P106
P1153
7102918885
P2456
P31
P3829
P496
0000-0002-1119-6040